BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 11857071)

  • 1. Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion.
    Garcia-Bañuelos J; Siller-Lopez F; Miranda A; Aguilar LK; Aguilar-Cordova E; Armendariz-Borunda J
    Gene Ther; 2002 Jan; 9(2):127-34. PubMed ID: 11857071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase-type plasminogen activator gene therapy in liver cirrhosis is mediated by collagens gene expression down-regulation and up-regulation of MMPs, HGF and VEGF.
    Bueno M; Salgado S; Beas-Zárate C; Armendariz-Borunda J
    J Gene Med; 2006 Nov; 8(11):1291-9. PubMed ID: 16958060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexpected pulmonary uptake of adenovirus vectors in animals with chronic liver disease.
    Smith JS; Tian J; Muller J; Byrnes AP
    Gene Ther; 2004 Mar; 11(5):431-8. PubMed ID: 14973536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis.
    Siller-López F; Sandoval A; Salgado S; Salazar A; Bueno M; Garcia J; Vera J; Gálvez J; Hernández I; Ramos M; Aguilar-Cordova E; Armendariz-Borunda J
    Gastroenterology; 2004 Apr; 126(4):1122-33; discussion 949. PubMed ID: 15057751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Akt gene therapy for cirrhotic rats with portal hypertension].
    Huang FZ; Deng G; Liu XY; Luo CQ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):31-7. PubMed ID: 18245901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated gene transfer of interferon alpha improves dimethylnitrosamine-induced liver cirrhosis in rat model.
    Suzuki K; Aoki K; Ohnami S; Yoshida K; Kazui T; Kato N; Inoue K; Kohara M; Yoshida T
    Gene Ther; 2003 May; 10(9):765-73. PubMed ID: 12704415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transduction with a simian virus 40 vector encoding insulin-like growth factor I reduces hepatic damage and the development of liver cirrhosis.
    Vera M; Sobrevals L; Zaratiegui M; Martinez L; Palencia B; Rodríguez CM; Prieto J; Fortes P
    Gene Ther; 2007 Feb; 14(3):203-10. PubMed ID: 17024107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated gene transfer into rat livers: comparative study of retrograde intrabiliary and antegrade intraportal administration.
    Kuriyama S; Yoshiji H; Nakai S; Deguchi A; Uchida N; Kimura Y; Inoue H; Kinekawa F; Ogawa M; Nonomura T; Masaki T; Kurokohchi K; Watanabe S
    Oncol Rep; 2005 Jan; 13(1):69-74. PubMed ID: 15583804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination gene therapy of HGF and truncated type II TGF-beta receptor for rat liver cirrhosis after partial hepatectomy.
    Ozawa S; Uchiyama K; Nakamori M; Ueda K; Iwahashi M; Ueno H; Muragaki Y; Ooshima A; Yamaue H
    Surgery; 2006 Apr; 139(4):563-73. PubMed ID: 16627068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localized adenovirus gene delivery using antiviral IgG complexation.
    Levy RJ; Song C; Tallapragada S; DeFelice S; Hinson JT; Vyavahare N; Connolly J; Ryan K; Li Q
    Gene Ther; 2001 May; 8(9):659-67. PubMed ID: 11406760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
    Laviña B; Gracia-Sancho J; Rodríguez-Vilarrupla A; Chu Y; Heistad DD; Bosch J; García-Pagán JC
    Gut; 2009 Jan; 58(1):118-25. PubMed ID: 18829979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrasplenic transplantation of syngenic hepatocytes modified by IFN-gamma gene ameliorates hepatic fibrosis in rats.
    Song E; Chen J; Wang K; Zhang H; Su F; Wang M; Heemann U
    Transpl Int; 2002 Oct; 15(9-10):472-8. PubMed ID: 12389079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice.
    Roderfeld M; Weiskirchen R; Wagner S; Berres ML; Henkel C; Grötzinger J; Gressner AM; Matern S; Roeb E
    FASEB J; 2006 Mar; 20(3):444-54. PubMed ID: 16507762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase plasminogen activator stimulates function of active forms of stromelysin and gelatinases (MMP-2 and MMP-9) in cirrhotic tissue.
    González-Cuevas J; Bueno-Topete M; Armendariz-Borunda J
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1544-54. PubMed ID: 16928215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated gene expression in the septal cells of cirrhotic rat livers.
    Nakamura T; Akiyoshi H; Saito I; Sato K
    J Hepatol; 1999 Jan; 30(1):101-6. PubMed ID: 9927156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repetitive and safe transgene expression in rat liver is achievable by adenoviral infusion into the common bile duct.
    Kuriyama S; Yoshiji H; Tominaga K; Tsujinoue H; Nakatani T; Tsujimoto T; Okuda H; Akahane T; Deguchi A; Nakai S; Masaki T; Uchida N
    Int J Mol Med; 2005 Oct; 16(4):503-8. PubMed ID: 16142379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous transfer of vascular endothelial growth factor and hepatocyte growth factor genes effectively promotes liver regeneration after hepatectomy in cirrhotic rats.
    Oe H; Kaido T; Furuyama H; Mori A; Imamura M
    Hepatogastroenterology; 2004; 51(60):1641-7. PubMed ID: 15532795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinatorial gene therapy induces regression of hepatic encephalopathy.
    Gálvez-Gastélum FJ; Garcia-Bañuelos JJ; Beas-Zárate C; Segura-Flores A; González H; Chaparro-Huerta V; Salazar-Montes A; Sandoval-Rodriguez AS; Bueno-Topete M; Lucano-Landeros S; Medina-Preciado D; Gonzalez-Garcia I; Armendáriz-Borunda J
    Gene Ther; 2011 Jan; 18(1):88-94. PubMed ID: 20703313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes.
    Park J; Ries J; Gelse K; Kloss F; von der Mark K; Wiltfang J; Neukam FW; Schneider H
    Gene Ther; 2003 Jul; 10(13):1089-98. PubMed ID: 12808439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ex vivo human model system to evaluate specificity of replicating and non-replicating gene therapy agents.
    Rots MG; Elferink MG; Gommans WM; Oosterhuis D; Schalk JA; Curiel DT; Olinga P; Haisma HJ; Groothuis GM
    J Gene Med; 2006 Jan; 8(1):35-41. PubMed ID: 16044485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.